In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp) 3 and La(XT), for the treatment of bone resorption disorders
Cawthray, J F, Weekes, D M, Sivak, O, Creagh, A L, Ibrahim, F, Iafrate, M, Haynes, C A, Wasan, K M, Orvig, C
Published in Chemical science (Cambridge) (01.11.2015)
Published in Chemical science (Cambridge) (01.11.2015)
Get full text
Journal Article
La(iii) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp) 3 and La(XT), and evaluation as treatments for bone resorption disorders
Weekes, D M, Cawthray, J F, Rieder, M, Syeda, J, Ali, M, Wasan, E, Kostelnik, T I, Patrick, B O, Panahifar, A, Al-Dissi, A, Cooper, D, Wasan, K M, Orvig, C
Published in Metallomics (19.07.2017)
Published in Metallomics (19.07.2017)
Get more information
Journal Article
In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disordersElectronic supplementary information (ESI) available: Speciation diagrams for metal-ligand complexes (Fig. S1 and S3), ITC analysis of H5XT-hydroxyapatite titration (Fig. S2), plasma concentrations of La(dpp)3 and La(XT) following IV dose of 1 mg kg−1 per day taken at beginning & end of trial (ng g−1 weight, mean ± SD, n = 6) (Table S1). See DOI: 10.1039/c5
Cawthray, J. F, Weekes, D. M, Sivak, O, Creagh, A. L, Ibrahim, F, Iafrate, M, Haynes, C. A, Wasan, K. M, Orvig, C
Year of Publication 13.10.2015
Year of Publication 13.10.2015
Get full text
Journal Article
In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp) sub(3) and La(XT), for the treatment of bone resorption disorders
Cawthray, J F, Weekes, D M, Sivak, O, Creagh, AL, Ibrahim, F, Iafrate, M, Haynes, CA, Wasan, K M, Orvig, C
Published in Chemical science (Cambridge) (01.10.2015)
Published in Chemical science (Cambridge) (01.10.2015)
Get full text
Journal Article
In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disorders† †Electronic supplementary information (ESI) available: Speciation diagrams for metal–ligand complexes (Fig. S1 and S3), ITC analysis of H5XT-hydroxyapatite titration (Fig. S2), plasma concentrations of La(dpp)3 and La(XT) following IV dose of 1 mg kg–1 per day taken at beginning & end of trial (ng g–1 weight, mean ± SD, n = 6) (Table S1). See DOI: 10.1039
Cawthray, J. F., Weekes, D. M., Sivak, O., Creagh, A. L., Ibrahim, F., Iafrate, M., Haynes, C. A., Wasan, K. M., Orvig, C.
Published in Chemical science (Cambridge) (03.08.2015)
Published in Chemical science (Cambridge) (03.08.2015)
Get full text
Journal Article
Identification and Specificity Studies of Small-Molecule Ligands for SH3 Protein Domains
Inglis, Steven R, Stojkoski, Cvetan, Branson, Kim M, Cawthray, Jacquie F, Fritz, Daniel, Wiadrowski, Emma, Pyke, Simon M, Booker, Grant W
Published in Journal of medicinal chemistry (21.10.2004)
Published in Journal of medicinal chemistry (21.10.2004)
Get full text
Journal Article